Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT07383025
Mavacamten Post-marketing Surveillance in Patients With Obstructive Hypertrophic Cardiomyopathy in Japan
Sponsor: Bristol-Myers Squibb
View on ClinicalTrials.gov
Summary
The purpose of this study is to assess the real-world effectiveness and safety of mavacamten in patients with obstructive hypertrophic cardiomyopathy (HCM) receiving mavacamten in Japan
Official title: Mavacamten Post-marketing Surveillance in Patients With Obstructive Hypertrophic Cardiomyopathy (oHCM) in Japan
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
200
Start Date
2025-05-21
Completion Date
2029-11-30
Last Updated
2026-02-03
Healthy Volunteers
Not specified
Interventions
DRUG
Mavacamten
According to the product label
Locations (1)
CMIC Co., Ltd
Tokyo, Japan